immunity News and Research

RSS

Study paves the way for efficient one-dose strategy to reduce scabies prevalence

One dose of an anti-parasite drug was just as effective as two at significantly reducing the spread of scabies, the contagious, intensely itchy skin condition, according to a new study.

10 Feb 2022

Study explores protection against Omicron and Delta infections by COVID-19 vaccination and previous infection

A new study demonstrated that infection- and vaccine-induced protection induced by the primary COVID-19 vaccination was much reduced for the Omicron BA.1 infection compared to the Delta infection.

10 Feb 2022

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

In two recent studies, researchers at Washington University School of Medicine in St. Louis found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants — at least in rodents — but that many antibody-based therapies may not be effective against it.

10 Feb 2022

Measuring T cell responses to SARS-CoV-2 vaccination and infection in healthcare workers with two different assays

The purpose of this study was to compare the OI TSPOT with the in-house PITCH ELISpot for reporting T cell responses specific to SARS-CoV-2 spike and structural proteins.

10 Feb 2022

Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

A study published on the bioRxiv* preprint server evaluates molnupiravir against a panel of relevant VOCs using three efficacy models: primary human airway epithelium organoids, a ferret model of upper respiratory disease, and a Roborovski dwarf hamster model for severe COVID-19.

9 Feb 2022

Machine learning highly effective at identifying SARS-CoV-2 variants

...

9 Feb 2022

Newborn antibodies following maternal COVID-19 vaccination persist for up to six months

A new study compares antibody levels in newborns born from mothers vaccinated against COVID-19 and to maternal infection with SARS-CoV-2.

9 Feb 2022

How SARS-CoV-2 infection progresses throughout the respiratory system

Researchers discuss the progression of SARS-CoV-2 infection throughout the respiratory epithelium.

9 Feb 2022

Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

Researchers describe the impact of changes in the Omicron variant on a uniquely immunodominant spike-encoded CD8+ T-cell epitope.

9 Feb 2022

Research lays the groundwork to better understand and treat Crohn's disease

A paper published this week in Immunity, a leading research journal highlighting discoveries in immunology by Cell Press, lays the groundwork to better understand and treat Crohn's disease, a type of Inflammatory Bowel Disease (IBD).

9 Feb 2022

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

The FDA will consider authorizing two doses of a COVID-19 vaccine for kids under 5 on an emergency basis, with the possibility for a third.

9 Feb 2022

Study compares the neutralizing potential of antibodies against two Omicron variants

A new study investigates if the two SARS-CoV-2 Omicron variants BA.1 and BA.2 are comparable with respect to their ability to evade the host immunity induced by vaccination or prior infection.

9 Feb 2022

Innate immune specificity is driven by the nervous system, study suggests

Research led by Washington State University scientists supports a novel theory that the innate immune system people are born with can respond differently to specific pathogens.

9 Feb 2022

Simulation of SARS-CoV-2 spread in the United States and India

Researchers used an ABM to simulate SARS-CoV-2 spread in the United States and India.

9 Feb 2022

Implications of the SARS-CoV-2 pandemic on influenza epidemics

A new study investigated the effect of low circulating seasonal influenza virus during the SARS-CoV-2 pandemic on the antibody titers against influenza during the same period.

9 Feb 2022

Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

Researchers investigated the dynamics and longevity of neutralizing antibody response up to 480 days after the onset of infection in convalescent COVID-19 patients.

9 Feb 2022

Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

In a new study, researchers revealed that the nucleotide-binding oligomerization domain-like receptors or NOD-like receptors family pyrin domain containing 3 (NLRP3) inflammasome is activated by the exosomes from plasma in COVID-19.

9 Feb 2022

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

Researchers have conducted a prospective, longitudinal cohort study to analyze COVID-19 immunity in patients with cancer.

9 Feb 2022

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Researchers looked at the efficiency of COVID-19 vaccines in preventing infection, hospitalization, and death in the general population of Sweden over the first nine months following vaccination.

9 Feb 2022

Polio, chickenpox, measles, now covid. It’s time to consult history on school vaccine mandates

The rapid spread of omicron across the nation — and the finding that vaccines continue to provide strong protection against severe disease — brings covid-19 one step closer, perhaps, to truly earning its place on the list of diseases that have been tamed by vaccines.

9 Feb 2022

immunity News and Research

Study paves the way for efficient one-dose strategy to reduce scabies prevalence

Study explores protection against Omicron and Delta infections by COVID-19 vaccination and previous infection

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

Measuring T cell responses to SARS-CoV-2 vaccination and infection in healthcare workers with two different assays

Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

Machine learning highly effective at identifying SARS-CoV-2 variants

Newborn antibodies following maternal COVID-19 vaccination persist for up to six months

How SARS-CoV-2 infection progresses throughout the respiratory system

Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

Research lays the groundwork to better understand and treat Crohn's disease

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

Study compares the neutralizing potential of antibodies against two Omicron variants

Innate immune specificity is driven by the nervous system, study suggests

Simulation of SARS-CoV-2 spread in the United States and India

Implications of the SARS-CoV-2 pandemic on influenza epidemics

Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Polio, chickenpox, measles, now covid. It’s time to consult history on school vaccine mandates

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News